Neogenomics

USA

Neogenomics

12701 Common Wealth Drive Suite 9

Douglas M. VanOort,
Chairman of the Board of Directors and Chief Executive Officer
Maher Albitar, M.D.,
Chief Medical Officer and Director of Research and Development
Robert Gasparini, M.S., CLSp(CG), CLDir,
Chief Scientific Officer, Board Member
George A. Cardoza,
Chief Financial Officer
Steven C. Jones,
Executive Vice President Finance, Chief Compliance Officer, Board Member
Robert H. Horel,
Vice President of Sales and Marketing

Oncology

Production

Blood cancer, Thyroid and vascular gland cancer, Virilia cancer, Muliebria cancer, Breast cancer, Lung cancer, Intestine cancer, Gastric cancer

NEO

Douglas M. VanOort,
Chairman of the Board of Directors and Chief Executive Officer
Robert P. Gasparini, M.S., CLSp(CG), CLDir,
Chief Scientific Officer, Board Member
Steven C. Jones,
Executive Vice President Finance, Chief Compliance Officer, Board Member
Michael T. Dent M.D.,
Board Member
Kevin C. Johnson,
Board Member
Raymond R. Hipp,
Board Member
William J. Robison,
Board Member

332.6300

Cell Technologies, Technologies, Pharmaceuticals, Chemistry